Testing is one piece of reopening, but experts are still relying on the help of a vaccine to keep the public safe. Researchers are increasingly optimistic that scientists are getting closer to development even though we’re barely months into identifying and learning about the novel strain of SARS. Human and clinical trials are well underway, but just when they’ll be ready for manufacturing and distribution is another story. What is a realistic timeline and does one exist? We asked Dr. Vincent Silenzio an expert in urban and global public health at Rutgers University. To read the full story.
Recent Posts
- Discovery of a protein that reverses Alzheimer’s and heals brain injuries stuns scientists.
- Register for the Postdoctoral Research Symposium by September 12th
- Join NJ ACTS Tomorrow 9/9 for a Special Seminar
- ‘A Dangerous Setback’: HIV/AIDS Activists Warn of Fallout from Medicaid, CDC Cuts.
- Why Caffeine Might Hold the Key to Preventing Sudden Infant Death Syndrome.
Categories
- Community (2,322)
- Covid (989)
- CTO Events (6)
- News (2,954)
- Pilots (21)